US 7,538,112 B2
HIV integrase inhibitors
John S. Wai, Harleysville, Pa. (US); Joseph P. Vacca, Telford, Pa. (US); Linghang Zhuang, Chalfont, Pa. (US); Boyoung Kim, Lansdale, Pa. (US); Terry A. Lyle, Lederach, Pa. (US); Catherine M. Wiscount, Allentown, Pa. (US); Melissa S. Egbertson, Ambler, Pa. (US); Lou Anne Neilson, Sellersville, Pa. (US); Mark Embrey, Harleysville, Pa. (US); Thorsten E. Fisher, Hatfield, Pa. (US); and Donnette D. Staas, Harleysville, Pa. (US)
Assigned to Merck & Co., Inc., Rahway, N.J. (US)
Appl. No. 11/579,772
PCT Filed May 03, 2005, PCT No. PCT/US2005/015200
§ 371(c)(1), (2), (4) Date Nov. 07, 2006,
PCT Pub. No. WO2005/110414, PCT Pub. Date Nov. 24, 2005.
Claims priority of provisional application 60/569150, filed on May 07, 2004.
Prior Publication US 2008/0287394 A1, Nov. 20, 2008
Int. Cl. C07D 487/14 (2006.01); A61K 31/5025 (2006.01); A61K 31/4985 (2006.01)
U.S. Cl. 514—250  [544/234] 13 Claims
 
1. A compound of Formula I, or a pharmaceutically acceptable salt thereof:

OG Complex Work Unit Drawing
wherein:
R1 is:
(1) —C1-6 alkyl,
(2) —C1-6 alkyl substituted with —OH, —O—C1-6 alkyl, —O—C1-6 haloalkyl, —CN, —NO2, —N(RA)RB, —C(O)N(RA)RB, —C(O)RA, —CO2RA, —SRA, —S(O)RA, —SO2RA, —SO2N(RA)RB, —N(RA)C(O)RB, —N(RA)CO2RB, —N(RA)SO2RB, —N(RA)SO2N(RA)RB, —OC(O)N(RA)RB, —N(RA)C(O)N(RA)RB, or —N(RA)C(O)C(O)N(RA)RB,
(3) —C3-8 cycloalkyl, which is optionally substituted with from 1 to 6 substituents each of which is independently halogen, —CN, —C1-6 alkyl, —OH, —O—C1-6 alkyl, —C1-6 haloalkyl, or —O—C1-6 haloalkyl,
(4) —C1-6 alkyl substituted with C3-8 cycloalkyl, wherein the C3-8 cycloalkyl is optionally substituted with from 1 to 6 substituents each of which is independently halogen, —CN, —C1-6 alkyl, —OH, —O—C1-6 alkyl, —C1-6 haloalkyl, or —O—C1-6 haloalkyl,
(5) heteroaryl, which is optionally substituted with from 1 to 5 substituents each of which is independently any one of substituents (1) to (26) as defined below in part (i) of Part B of the definition of RJ,
(6) —C1-6 alkyl substituted with RJ, wherein RJ is:
(A) aryl which is:
(i) optionally substituted with from 1 to 5 substituents each of which is independently:
(1) —C1-6 alkyl, which is optionally substituted with —OH, —O—C1-6 alkyl, —O—C1-6 haloalkyl, —CN, —NO2, —N(RA)RB, —C(O)N(RA)RB, —C(O)RA, —CO2RA, —SRA, —S(O)RA, —SO2RA, —SO2N(RA)RB, —N(RA)C(O)RB, —N(RA)CO2RB, —N(RA)SO2RB, —N(RA)SO2N(RA)RB, —OC(O)N(RA)RB, —N(RA)C(O)N(RA)RB, or —N(RA)C(O)C(O)N(RA)RB,
(2) —O—C1-6 alkyl,
(3) —C1-6 haloalkyl,
(4) —O—C1-6 haloalkyl,
(5) —OH,
(6) halogen,
(7) —CN,
(8) —NO2,
(9) —N(RA)RB,
(10) —C(O)N(RA)RB,
(11) —C(O)RA,
(12) —CO2RA,
(13) —SRA,
(14) —S(O)RA,
(15) —SO2RA,
(16) —SO2N(RA)RB,
(17) —N(RA)SO2RB,
(18) —N(RA)SO2N(RA)RB,
(19) —N(RA)C(O)RB,
(20) —N(RA)C(O)—C(O)N(RA)RB, or
(21) —N(RA)CO2RB, and
(ii) optionally substituted with 1 or 2 substituents each of which is independently:
(1) —C3-8 cycloalkyl,
(2) aryl,
(3) —C1-6 alkyl substituted with aryl, —C3-8 cycloalkyl, HetA, or HetB,
(4) -HetA,
(5) —C(O)-HetA; or
(6) -HetB;
wherein:
 each cycloalkyl is optionally substituted with from 1 to 6 substituents each of which is independently halogen, —CN, —C1-6 alkyl, —OH, —O—C1-6 alkyl, —C1-6 haloalkyl, or —O—C1-6 haloalkyl,
 each aryl is optionally substituted with from 1 to 5 substituents each of which is independently any one of the substituents (1) to (21) as defined above in part (i) of Part A of the definition of RJ,
 each HetA is independently (i) a —C4-7 azacycloalkyl or oxacycloalkyl or thiacycloalkyl or (ii) a —C3-6 diazacycloalkyl or oxazacycloalkyl or thiazacycloalkyl, wherein the S in the thiacycloalkyl or thiazacycloalkyl is optionally oxidized to S(O) or SO2, and wherein any of the rings defined in (i) or (ii) is optionally substituted with from 1 to 4 substituents each of which is independently oxo, —C1-6 alkyl, —C(O)RA, —CO2RA, —SRA, —S(O)RA, or —S(O)2RA; and
 each HetB is independently a 5- or 6-membered heteroaromatic ring containing from 1 to 4 heteroatoms independently selected from N, O and S, wherein the heteroaromatic ring is optionally substituted with from 1 to 4 substituents each of which is independently any one of the substituents (1) to (26) as defined below in part (i) of Part B of the definition of RJ, or
(B) heteroaryl which is:
(i) optionally substituted with from 1 to 6 substituents each of which is independently:
(1) —C1-6 alkyl,
(2) —C1-6 alkyl substituted with —OH, —O—C1-6 alkyl, —O—C1-6 haloalkyl, —CN, —NO2, —N(RA)RB, —C(O)N(RA)RB, —C(O)RA, —CO2RA, —SRA, —S(O)RA, —S(O)2RA, —S(O)2N(RA)RB, —N(RA)C(O)RB, —N(RA)CO2RB, —N(RA)S(O)2RB, —N(RA)S(O)2N(RA)RB, —OC(O)N(RA)RB, —N(RA)C(O)N(RA)RB, or —N(RA)C(O)C(O)N(RA)RB,
(3) —O—C1-6 alkyl,
(4) —C1-6 haloalkyl,
(5) —O—C1-6 haloalkyl,
(6) —OH,
(7) -oxo,
(8) halogen,
(9) —CN,
(10) —NO2,
(11) —N(RA)RB,
(12) —C(O)N(RA)RB,
(13) —C(O)RA,
(14) —C(O)—C1-6 haloalkyl,
(15) —C(O)ORA,
(16) —OC(O)N(RA)RB,
(17) —SRA,
(18) —S(O)RA,
(19) —S(O)2RA,
(20) —S(O)2N(RA)RB,
(21) —N(RA)S(O)2RB,
(22) —N(RA)S(O)2N(RA)RB,
(23) —N(RA)C(O)RB,
(24) —N(RA)C(O)N(RA)RB,
(25) —N(RA)C(O)—C(O)N(RA)RB, or
(26) —N(RA)CO2RB, and
(ii) optionally substituted with 1 or 2 substituents each of which is independently:
(1) —C3-8 cycloalkyl,
(2) aryl,
(3) —C1-6 alkyl substituted with aryl, —C3-8 cycloalkyl, HetA, or HetB,
(4) -HetA,
(5) —C(O)-HetA; or
(6) -HetB;
wherein:
 each cycloalkyl is optionally substituted with from 1 to 6 substituents each of which is independently halogen, —CN, —C1-6 alkyl, —OH, —O—C1-6 alkyl, —C1-6 haloalkyl, or —O—C1-6 haloalkyl,
 each aryl is optionally substituted with from 1 to 5 substituents each of which is independently any one of the substituents (1) to (21) as defined above in part (i) of Part A of the definition of RJ,
 each HetA is independently as defined in Part (A)(ii) of the definition of RJ, and
 each HetB is independently as defined in Part (A)(ii) of the definition of RJ;
(7) aryl, which is optionally substituted with from 1 to 5 substituents each of which is independently any one of the substituents (1) to (21) as defined above in part (i) of Part A of the definition of RJ;
R2 is:
(1) —H,
(2) —C1-6 alkyl,
(3) —C1-6 haloalkyl,
(4) —C1-6 alkyl substituted with —OH, —O—C1-6 alkyl, —O—C1-6 haloalkyl, —CN, —NO2, —N(RA)RB, —C(O)N(RA)RB, —C(O)RA, —CO2RA, —SRA, —S(O)RA, —SO2RA, —SO2N(RA)RB, —N(RA)C(O)RB, —N(RA)CO2RB, —N(RA)SO2RB, —N(RA)SO2N(RA)RB, —OC(O)N(RA)RB, —N(RA)C(O)N(RA)RB, or —N(RA)C(O)C(O)N(RA)RB, or
(5) —C1-6 alkyl substituted with HetC, —C(O)-HetC, —SO2-HetC, —N(RA)C(O)-HetC, or —N(RA)C(O)C(O)-HetC;
wherein HetC is a 4- to 7-membered, saturated or mono-unsaturated heterocyclic ring containing from 1 to 3 heteroatoms independently selected from 1 to 3 N atoms, zero to 1 O atom, and zero to 1 S atom, where the S is optionally oxidized to S(O) or S(O)2, with the proviso that the ring is attached to the rest of the molecule via a ring N atom, and wherein the saturated or mono-unsaturated heterocyclic ring is optionally substituted with from 1 to 4 substituents each of which is independently halogen, —CN, —C1-6 alkyl, —OH, oxo, —C(O)RA, —CO2RA, —S(O)RA, —SRA, —S(O)2RA, —CH2—CH═CH2, —O—C1-6 alkyl, —C1-6 haloalkyl, —C1-6 alkylene-CN, —C1-6 alkylene-OH, or —C1-6 alkylene-O—C1-6 alkyl;
or alternatively R1 and R2 together with the ring nitrogen to which R1 is attached and the ring carbon to which R2 is attached form a 5- to 7-membered, saturated heterocyclic ring in which the portion of the ring formed from R1 and R2 is a 3- to 5-membered methylene chain in which one of the methylene moieties is optionally replaced with N(H), wherein the chain is optionally substituted with from 1 to 3 substituents each of which is independently —C1-6 alkyl, —OH, or oxo;
R3 is:
(1) —H,
(2) —C1-6 alkyl,
(3) —C1-6 haloalkyl,
(4) —C1-6 alkyl substituted with —OH, —O—C1-6 alkyl, —O—C1-6 haloalkyl, —CN, —NO2, —N(RA)RB, —C(O)N(RA)RB, —C(O)RA, —CO2RA, —SRA, —S(O)RA, —SO2RA, —SO2N(RA)RB, —N(RA)C(O)RB, —N(RA)CO2RB, —N(RA)SO2RB, —N(RA)SO2N(RA)RB, —OC(O)N(RA)RB, —N(RA)C(O)N(RA)RB, or —N(RA)C(O)C(O)N(RA)RB,
(5) —C1-6 alkyl substituted with HetD, —C(O)-HetD, —SO2-HetD, —N(RA)C(O)-HetD, or —N(RA)C(O)C(O)-HetD,
(6) CycM, AryM, or HetM, or
(7) —C1-6 alkyl substituted with CycM, AryM, or HetM;
wherein:
HetD independently has the same definition as HetC;
CycM is —C3-8 cycloalkyl which is optionally substituted with from 1 to 6 substituents each of which is independently halogen, —CN, —C1-6 alkyl, —OH, —O—C1-6 alkyl, —C1-6 haloalkyl, or —O—C1-6 haloalkyl;
AryM is aryl, which is optionally substituted with from 1 to 5 substituents each of which is independently any one of the substituents (1) to (21) as defined above in part (i) of Part A of the definition of RJ; and
HetM is heteroaryl, which is optionally substituted with from 1 to 5 substituents each of which is independently any one of the substituents (1) to (26) as defined above in part (i) of Part B of the definition of RJ;
or alternatively R2 and R3 together with the carbon atoms to which they are attached form:
(i) a 3- to 8-membered saturated carbocyclic ring which is optionally substituted with from 1 to 6 substituents each of which is independently halogen, —CN, —C1-6 alkyl, —OH, —O—C1-6 alkyl, —C1-6 haloalkyl, or —O—C1-6 haloalkyl,
(ii) a benzene ring, which is optionally substituted with from 1 to 4 substituents each of which is independently any one of the substituents (1) to (21) as defined above in part (i) of Part A of the definition of RJ,
(iii) a 4- to 7-membered, saturated or mono-unsaturated heterocyclic ring containing from 1 to 3 heteroatoms independently selected from N, O and S, where each S is optionally oxidized to S(O) or S(O)2, and wherein the saturated or mono-unsaturated heterocyclic ring is optionally substituted with from 1 to 4 substituents each of which is independently halogen, —CN, —C1-6 alkyl, —OH, oxo, —C(O)RA, —CO2RA, —S(O)RA, —SRA, —S(O)2RA, —CH2—CH═CH2, —O—C1-6 alkyl, —C1-6 haloalkyl, —C1-6 alkylene-CN, —C1-6 alkylene-OH, or —C1-6 alkylene-O—C1-6 alkyl, or
(iv) a 5- or 6-membered heteroaromatic ring, which is optionally substituted with from 1 to 3 substituents each of which is independently any one of the substituents (1) to (26) as defined above in part (i) of Part B of the definition of RJ;
wherein R6 and R7 are absent, when R2 and R3 together with the carbon atoms to which they are attached form a benzene ring or a heteroaromatic ring;
R4 is:
(1) —H,
(2) —C1-6 alkyl,
(3) —C1-6 haloalkyl,
(4) —C1-6 alkyl substituted with —OH, —O—C1-6 alkyl, —O—C1-6 haloalkyl, —CN, —NO2, —N(RA)RB, —C(O)N(RA)RB, —C(O)RA, —CO2RA, —SRA, —S(O)RA, —SO2RA, —SO2N(RA)RB, —N(RA)C(O)RB, —N(RA)CO2RB, —N(RA)SO2RB, —N(RA)SO2N(RA)RB, —OC(O)N(RA)RB, —N(RA)C(O)N(RA)RB, or —N(RA)C(O)C(O)N(RA)RB,
(5) —OH,
(6) —O—C1-6 alkyl,
(7) —O—C1-6 haloalkyl,
(8) —CN,
(9) —NO2,
(10) —N(RC)RD,
(11) —C(O)N(RC)RD,
(12) —C(O)RA,
(13) —CO2RA,
(14) —SRA,
(15) —S(O)RA,
(16) —SO2RA,
(17) —SO2N(RA)RB,
(18) —N(RA)C(O)RB,
(19) —N(RA)CO2RB,
(20) —N(RA)SO2RB,
(21) —N(RA)SO2N(RA)RB,
(22) —OC(O)N(RA)RB,
(23) —N(RA)C(O)N(RA)RB,
(24) —N(RA)C(O)C(O)N(RA)RB,
(25) halogen,
(26) —S—C(O)N(RC)RD,
(27) —N═C(RA)—N(RC)RD,
(28) —C(O)N(RA)—C1-6 alkylene-N(RC)RD,
(29) —C(O)—C1-6 alkylene-N(RC)RD,
(30) —C(O)N(RA)—C1-6 alkylene-C1-6 haloalkyl,
(31) —C(O)—C1-6 alkylene-C1-6 haloalkyl,
(32) —N(SO2RA)—V,
(33) —N[C(O)RA]—V,
(34) —C1-6 alkyl substituted HetE, —C(O)-HetE, —SO2-HetE, —N(RA)C(O)-HetE, or —N(RA)C(O)C(O)-HetE,
(35) —C1-6 alkyl substituted with CycL, AryL, HetL, or HetS, or
(36) —T—RL,
wherein:
T is a single bond, O, C(O), C(O)N(RA), N(RA)C(O), S, S(O), S(O)2, N(RA)S(O)2, S(O)2N(RA), O—C1-6 alkylene, C(O)—C1-6 alkylene, C(O)N(RA)—C1-6 alkylene, N(RA)C(O)—C1-6 alkylene, S—C1-6 alkylene, S(O)—C1-6 alkylene, S(O)2—C1-6 alkylene, C1-6 alkylene-S, C1-6 alkylene-S(O), C1-6 alkylene-S(O)2, C1-6 alkylene-O, C1-6 alkylene-C(O), C1-6 alkylene-C(O)N(RA), C1-6 alkylene-N(RA)C(O), C1-6 alkylene-N(RA)S(O)2, or C1-6 alkylene-S(O)2N(RA);
V is (i) —CH2—C2-6 alkenyl or (ii) —C1-6 alkyl substituted with C(O)N(RC)RD, CycL, AryL, HetL, or HetS; and
RL is CycL, AryL, HetL, or HetS;
CycL is —C3-8 cycloalkyl which is optionally substituted with from 1 to 6 substituents each of which is independently halogen, —CN, —C1-6 alkyl, —OH, —O—C1-6 alkyl, —C1-6 haloalkyl, or —O—C1-6 haloalkyl;
AryL is aryl, which is optionally substituted with from 1 to 5 substituents each of which is independently any one of the substituents (1) to (21) as defined above in part (i) of Part A of the definition of RJ;
HetE independently has the same definition as HetC;
HetL is heteroaryl, which is optionally substituted with from 1 to 5 substituents each of which is independently any one of the substituents (1) to (26) as defined above in part (i) of Part B of the definition of RJ;
HetS is a 4- to 7-membered, saturated or mono-unsaturated heterocyclic ring containing at least one carbon atom and from 1 to 4 heteroatoms independently selected from N, O and S, where each S is optionally oxidized to S(O) or S(O)2, with the proviso that HetS is attached to the rest of the molecule via a ring carbon atom; and wherein the saturated or mono-unsaturated heterocyclic ring is optionally substituted with from 1 to 4 substituents each of which is independently halogen, —CN, —C1-6 alkyl, —OH, oxo, —C(O)RA, —CO2RA, —S(O)RA, —SRA, —S(O)2RA, —CH2—CH═CH2, —O—C1-6 alkyl, —C1-6 haloalkyl, —C1-6 alkylene-C(O)N(RA)RB, —C1-6 alkylene-CN, —C1-6 alkylene-OH, or —C1-6 alkylene-O—C1-6 alkyl;
R5 is:
(1) —C1-6 alkyl,
(2) —C1-6 alkyl substituted with —OH, —O—C1-6 alkyl, —O—C1-6 haloalkyl, —CN, —NO2, —N(RA)RB, —C(O)N(RA)RB, —C(O)RA, —CO2RA, —SRA, —S(O)RA, —SO2RA, —SO2N(RA)RB, —N(RA)C(O)RB, —N(RA)CO2RB, —N(RA)SO2RB, —N(RA)SO2N(RA)RB, —OC(O)N(RA)RB, —N(RA)C(O)N(RA)RB, or —N(RA)C(O)C(O)N(RA)RB,
(3) —C3-8 cycloalkyl, which is optionally substituted with from 1 to 6 substituents each of which is independently halogen, —CN, —C1-6 alkyl, —OH, —O—C1-6 alkyl, —C1-6 haloalkyl, or —O—C1-6 haloalkyl,
(4) —C1-6 alkyl substituted with —C3-8 cycloalkyl, wherein the —C3-8 cycloalkyl is optionally substituted with from 1 to 6 substituents each of which is independently halogen, —CN, —C1-6 alkyl, —OH, —O—C1-6 alkyl, —C1-6 haloalkyl, or —O—C1-6 haloalkyl,
(5) heteroaryl, which is optionally substituted with from 1 to 5 substituents each of which is independently any one of the substituents (1) to (26) as defined above in part (i) of Part B of the definition of RJ,
(6) —C1-6 alkyl substituted with RK, wherein RK independently has the same definition as RJ as set forth above in the definition of R1, or
(7) aryl, which is optionally substituted with from 1 to 5 substituents each of which is independently any one of the substituents (1) to (21) as defined above in part (i) of Part A of the definition of RJ;
and with the proviso that R5 is —C1-6 alkyl substituted with RK, when R1 is other than —C1-6 alkyl substituted with RJ;
R6 and R7 are each independently —H or —C1-6 alkyl;
or alternatively R3 and R7 together with the carbon atom to which they are attached form (i) a 3- to 8-membered saturated carbocyclic ring which is optionally substituted with from 1 to 6 substituents each of which is independently halogen, —CN, —C1-6 alkyl, —OH, —O—C1-6 alkyl, —C1-6 haloalkyl, or —O—C1-6 haloalkyl or (ii) a 4- to 7-membered, saturated or mono-unsaturated heterocyclic ring containing from 1 to 3 heteroatoms independently selected from N, O and S, where each S is optionally oxidized to S(O) or S(O)2, and wherein the saturated or mono-unsaturated heterocyclic ring is optionally substituted with from 1 to 4 substituents each of which is independently halogen, —CN, —C1-6 alkyl, —OH, oxo, —C(O)RA, —CO2RA, —S(O)RA, —SRA, —S(O)2RA, —CH2—CH═CH2, —O—C1-6 alkyl, —C1-6 haloalkyl, —C1-6 alkylene-CN, —C1-6 alkylene-OH, or —C1-6 alkylene-O—C1-6 alkyl,
each aryl is independently (i) phenyl, (ii) a 9- or 10-membered bicyclic, fused carbocyclic ring system in which at least one ring is aromatic, or (iii) an 11- to 14-membered tricyclic, fused carbocyclic ring system in which at least one ring is aromatic;
each heteroaryl is independently (i) a 5- or 6-membered heteroaromatic ring containing from 1 to 4 heteroatoms independently selected from N, O and S, wherein each N is optionally in the form of an oxide, or (ii) a 9- or 10-membered bicyclic, fused ring system containing from 1 to 4 heteroatoms independently selected from N, O and S, wherein either one or both of the rings contain one or more of the heteroatoms, at least one ring is aromatic, each N is optionally in the form of an oxide, and each S in a ring which is not aromatic is optionally S(O) or S(O)2;
each RA is independently —H or —C1-6 alkyl;
each RB is independently —H or —C1-6 alkyl;
each RC is independently —H or —C1-6 alkyl; and
each RD is independently —H or —C1-6 alkyl;
or alternatively RC and RD together with the N to which they are both attached form a 4- to 7-membered, saturated or mono-unsaturated heterocyclic ring containing the N to which they are both attached and optionally containing 1 or 2 additional heteroatoms independently selected from N, O and S, where each S is optionally oxidized to S(O) or S(O)2, and wherein the saturated or mono-unsaturated heterocyclic ring is optionally substituted with from 1 to 4 substituents each of which is independently halogen, —CN, —C1-6 alkyl, —OH, oxo, —C(O)RA, —CO2RA, —S(O)RA, —SRA, —S(O)2RA, —CH2—C2-6 alkenyl, —O—C1-6 alkyl, —C1-6 haloalkyl, —C1-6 alkylene-CN, —C1-6 alkylene-OH, or —C1-6 alkylene-O—C1-6 alkyl.